Determinar prevalencia hemoglobina alta y morbilidad asociada a gestantes. Hospital de Especialidades José Carrasco Arteaga, 2017–2019

Abstract

Background: according to the World Health Organization, high hemoglobin is associated with gestational risk, being the active cause of maternal-fetal morbidity and mortality, no studies in the country and absent in state guidelines. Objective: to determine prevalence of pregnant women with high hemoglobin and to identify its association with perinatal morbidity, at the José Carrasco Arteaga Specialty Hospital (HEJCA) period 2017 – 2019. Methodology: an analytical, cross-sectional and retrospective study was carried out; with a universe of 3650 clinical records of pregnant seen in the HEJCA 2017 - 2019, the sample of 316 patients was calculated, tabulated and analyzed with SPSS19 and Excel2019, high maternal hemoglobin was associated with the development or not of complications, with odds ratio, 95% confidence index and p value, in 2 x 2 tables, sociodemographic variables, trimester of pregnancy and iron supplementation were also related. Results: the population was 316, the majority age group was 22-32 years old, 95% were supplemented with iron. The prevalence of pregnant women with high hemoglobin was 60.44%. Perinatal morbidity was identified in 10.47% of patients with high hemoglobin, preeclampsia being the most frequent. There was a statistically significant relationship between high hemoglobin in the second and third trimesters with preeclampsia (OR: 2,120 IC al 95%: 1,609 – 2,792; p: 0,001); (OR: 1,502 IC al 95%: 1,143 – 2,107; p: 0,038). Gestational diabetes had a statistical association in the second trimester (OR: 2,504 IC al 95%: 2,186 – 2,868; p: 0,035). Conclusions: There is a high prevalence of high hemoglobin and it is associated with maternal-fetal morbidity.